Tandem Diabetes Care Forecast and Stock Analysis
Technical TNDM stock analysis for Friday May 24, 2019.
|Price to book||USD 32.15|
|Next Earnings Date||2019-07-28|
Tandem Diabetes Care gained 2.24% in the last trading day ( Friday, 24th May 2019 ), rising from $63.93 to $65.36 During day the stock fluctuated 2.46% from a day low at $64.30 to a day high of $65.88. The price has been going up and down for this period, and there has been a 1.15% gain for the last 2 weeks. Volume fell in the last day by -775 276 shares, and in total, 642 948 shares bought and sold for approximately $42.02 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
- 30 day high of the TNDM stock price was $72.04 and low was $56.68.
- 90 day high was $74.81 and low was $47.36.
- 52 week high for the Tandem Diabetes Care - $74.81 and low - $11.62.
Given the current horizontal trend you can expect Tandem Diabetes Care with 90% probability to be traded between $54.31 and $73.41 at the end of this period with 90% probability. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the roof. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Tandem Diabetes Care holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $66.73. On a fall, the stock will find some support from the long-term average at approximately $63.35. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Thursday May 23, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.
Relative Strength Index (RSI)
RSI14 is 46 and the stock is currently not being overbought or oversold
Support & Resistance
Tandem Diabetes Care finds support from accumulated volume at $64.47.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.58 between high and low, or 2.46%. For the last week, the stock has had a daily average volatility of 3.37%.
Our recommended stoploss: $61.97 (-5.18%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)
3.37 %Average volatility
Very Low Low Medium High Very High
Tandem Diabetes Care holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|TNDM $65.36 ($1.43 2.24%)|
TNDM is up $1.43 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for TNDM based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the TNDM analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us